LLY vs MDT
By Alex · Tickerpine
Eli Lilly and Company vs Medtronic plc, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | MDT |
|---|---|---|
| Price | $1,184.78 | $89.50 |
| Market cap | $1.06T | $114.48B |
| P/E ratio | 39.7 | 21.8 |
| ROE | 102.29% | 10.65% |
| Profit margin | 33.53% | 13.93% |
| Revenue growth | 47.70% | 13.70% |
| Dividend yield | 0.58% | 3.22% |
| Beta | 0.50 | 0.57 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs MDT in plain English
- LLY is the bigger company — about 9.2× the market cap of MDT.
- MDT is cheaper on earnings (P/E 21.8 vs 39.7).
- LLY earns a higher return on equity (102% vs 11%).
- LLY is growing revenue faster (48% vs 14%).
- MDT has the higher dividend yield (3.22% vs 0.58%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
MDT return calculator
See what $1,000 in Medtronic plc would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.